[Form 4] PRECIGEN, INC. Insider Trading Activity

Rhea-AI Filing Summary

Rutul R. Shah, Chief Operating Officer and director of Precigen, Inc. (PGEN), reported a purchase of 2,000 shares of Precigen common stock on 09/26/2025 at a reported price of $3.40 per share. After this transaction the reporting person beneficially owned 405,959 shares. The Form 4 was signed on behalf of Mr. Shah by an attorney-in-fact on 09/30/2025. The filing indicates the form was submitted by one reporting person and does not disclose any derivative transactions or additional changes to ownership beyond the common stock purchase.

Positive

• Insider purchase reported: COO and director acquired 2,000 shares, signaling additional insider ownership alignment with shareholders.
• Clear disclosure: Form 4 lists transaction date, price ($3.40), and updated beneficial ownership (405,959 shares), providing transparent reporting.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Officer purchase increases insider alignment with shareholders but appears routine and not materially transformative.

The reported acquisition of 2,000 shares by the COO and director demonstrates additional insider ownership, which can align management incentives with shareholders. The transaction size relative to the total holding (405,959 shares post-transaction) is modest and the filing shows no related derivative activity or disposition. There is no indication of unusual timing, related-party transaction, or amendment to prior disclosures. Impact on governance is positive in alignment terms but not material in scale.

Securities Analyst

TL;DR: Small open-market purchase reported; not material to valuation but useful for monitoring insider behavior.

The Form 4 discloses an open-market purchase coded as P for 2,000 shares at $3.40, increasing beneficial ownership to 405,959 shares. This single non-derivative purchase is straightforward and provides a data point for insider buying activity. It does not include options, warrants, or other derivatives, and no sale or significant change in total ownership is reported. From a market-impact perspective the trade is immaterial.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Shah Rutul R

(Last) (First) (Middle)

20374 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN MD 20876

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/26/2025		P		2,000	A	$3.4	405,959	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Rutul R. Shah, by Donald P. Lehr, as attorney-in-fact	09/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Precigen (PGEN) insider Rutul R. Shah report on Form 4?

The filing reports a purchase of 2,000 shares of common stock on 09/26/2025 at $3.40 per share, increasing his beneficial ownership to 405,959 shares.

What is the transaction code and meaning in this Form 4 for PGEN?

The transaction is coded P, indicating an open-market purchase of the issuer's common stock as reported on the Form 4.

Were any derivative securities reported by the insider in this filing?

No. Table II for derivative securities contains no reported transactions or holdings; only a non-derivative common stock purchase is disclosed.

Who signed the Form 4 for Rutul R. Shah and when?

The Form 4 was signed on behalf of Rutul R. Shah by an attorney-in-fact, Donald P. Lehr, on 09/30/2025.

Does this Form 4 indicate a material change in ownership for PGEN?

The filing shows a modest purchase of 2,000 shares and a total beneficial holding of 405,959 shares; the document does not state any material change beyond that purchase.